Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Argus Health
Cipla
Dow
Mallinckrodt
Fuji
US Army
Baxter
Citi

Generated: December 11, 2018

DrugPatentWatch Database Preview

Tentative Approvals

« Back to Dashboard

Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Mylan Pharms Inc sunitinib malate 201275 EQ 50MG BASE CAPSULE;ORAL
Alembic Pharms Ltd asenapine 206098 10MG TABLET;SUBLINGUAL
Wockhardt Usa pregabalin 091222 50MG CAPSULE; ORAL
Actavis Elizabeth lisdexamfetamine dimesylate 202802 30MG CAPSULE;ORAL
Pharmaforce oxaliplatin 204378 100MG/20ML (5MG/ML) INJECTABLE; IV (INFUSION)
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Boehringer Ingelheim
US Department of Justice
Julphar
Medtronic
UBS
Cerilliant
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.